Alnylam Pharmaceuticals, Inc.

Report date
12/31/2025
Quarter
2025 Q4
Filed
2/17/2026
Shares
288,800
Value ($000)
114,841
Weight
2.4%
2022 Q3 - 2025 Q4 (9 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).